Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Patient Transitioning From Exubera®

Very good news. Unsurprisingly no safety issues for the 16 patients.

Thanks Brentie. You continue to amaze with your data mining and are a real asset to anyone doing due diligence on Afrezza.

Swing

Share
New Message
Please login to post a reply